Seres Therapeutics (MCRB) Selling, General & Administrative (2014 - 2026)
Seres Therapeutics (MCRB) recorded Selling, General & Administrative of $7.06 million in Q2 2026, down 31.1% from $10.25 million a year earlier and down 12.5% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Selling, General & Administrative (2014 - 2026) Analysis & Trends
On a TTM basis, Seres Therapeutics' Selling, General & Administrative came in at $32.15 million as of Jun 30, 2026, down 32.1% year-over-year; for FY2025, it came in at $39.16 million, down 26.4% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $53.18 million in FY2024 (-31.4%), $77.5 million in FY2023 (+10.3%), $70.26 million in FY2022 (+1.4%) and $69.26 million in FY2021 (+125.1%).
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q2 2020.
- On a year-over-year basis, Selling, General & Administrative has declined for ten consecutive quarters, with an average decline of 27.0% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 159.1% in Q3 2021, against a decline of 53.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.07 million (Q1 2026), $7.54 million (Q4 2025) and $9.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Seres Therapeutics | 20.29 Mn | -118.55 Mn | - | 7.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.06 Mn |
| Mar 31, 2026 | 8.07 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 9.48 Mn |
| Jun 30, 2025 | 10.25 Mn |
| Mar 31, 2025 | 11.89 Mn |
| Dec 31, 2024 | 12.46 Mn |
| Sep 30, 2024 | 12.71 Mn |
| Jun 30, 2024 | 13.07 Mn |
| Mar 31, 2024 | 14.94 Mn |
| Dec 31, 2023 | 13.98 Mn |
| Sep 30, 2023 | 19.43 Mn |
| Jun 30, 2023 | 28.05 Mn |
| Mar 31, 2023 | 22.47 Mn |
| Dec 31, 2022 | 12.97 Mn |
| Sep 30, 2022 | 18.38 Mn |
| Jun 30, 2022 | 20.34 Mn |
| Mar 31, 2022 | 18.57 Mn |
| Dec 31, 2021 | 20.51 Mn |
| Sep 30, 2021 | 19.56 Mn |
API Access
Seres Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();